HPV16 E7 Antibodies

Santa Cruz Biotechnology features a diverse variety of HPV16 E7 monoclonal antibodies for investigating the role of HPV16 E7 protein in cellular processes. HPV16 E7 Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HPV16 E7 protein functions as a key oncoprotein that drives the transformation of host cells by promoting cell cycle progression and inhibiting apoptosis. The interaction between HPV16 E7 and host cell proteins, particularly the retinoblastoma protein, highlights its significance in cervical cancer development and other HPV-related malignancies. Research focused on HPV16 E7 continues to reveal new insights about viral mechanisms and potential therapeutic targets. Scientists worldwide rely on HPV16 E7 monoclonal antibodies to explore viral oncogenesis and disease progression. Understanding HPV16 E7 mechanisms is crucial for developing new therapeutic strategies and improving diagnostic approaches for HPV-associated diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing innovative solutions for HPV-related cancers.